Current concepts on cytomegalovirus infection after liver transplantation

doi:10.4254/wjh.v2.i9.325

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3983)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

574

HTML

3095

Figures (1-3)

152

Tables (1-4)

162

Sum=3983

Sep 27, 2010 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hepatol. Sep 27, 2010; 2(9): 325-336
Published online Sep 27, 2010. doi: 10.4254/wjh.v2.i9.325

Full Size Figure Download Figure

Figure 3 Proportion of solid organ transplant patients with resolution of clinical symptoms (panel A) and viremia eradication (panel B) at day 21 and 49 following the start of valganciclovir or intravenous ganciclovir treatment of CMV disease. Data obtained from the study by Asberg and colleagues[79].

Citation: Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol 2010; 2(9): 325-336
URL: https://www.wjgnet.com/1948-5182/full/v2/i9/325.htm
DOI: https://dx.doi.org/10.4254/wjh.v2.i9.325